New England Retina Associates
Hamden, Connecticut 06518
0 studies enrolling now · 14 studies all time
What they study most
Choroidal Melanoma, Choroidal Neovascularization, Diabetic Macular Edema, Diabetic Retinopathy, Geographic Atrophy, Macular Degeneration, Macular Edema, Retinal Vein Occlusion, Sarcoid Uveitis, Vitreous Hemorrhage
Studies at this site
- Anti-VEGF Treatment for Prevention of PDR/DME — Completed
- Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration — Completed
- Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA) — Completed
- Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO — Stopped early
- A Proof-of-Concept Study of Faricimab (RO6867461) in Participants With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) — Completed
- A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration — Stopped early
- (ACTH) for the Treatment of Sarcoid Uveitis — Status unconfirmed
- Lucentis as an Adjuvant Therapy With TTT-ICG Based in Choroidal Melanoma — Completed
- Ranibizumab as Adjuvant Therapy for the Treatment of Choroidal Melanoma (Cohort 2) — Completed
- A Study to Compare rhuFab V2 With Verteporfin Photodynamic in Treating Subfoveal Neovascular Macular Degeneration — Completed
- Long Term Results of Combined Transpupillary Thermotherapy (TTT) Indocyanine Green (ICG) Based Photodynamic Therapy (PDT) in Choroidal Melanoma — Completed
- Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage — Completed
- Pegaptanib Sodium Compared to Sham Injection in Patients With Recent Vision Loss Due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO) — Completed
- Intravitreous Pegaptanib Sodium Injection in Patients With Exudative Age-Related Macular Degeneration (AMD) — Completed